Healthcare and Medical
Healthcare and Medical
home | healthcare and medical | company profile
Premium Company Profile - Elan Corporation plc (Datamonitor)
- Market: Healthcare and Medical
- Published Date: 19/10/2007
- Report Title: Premium Company Profile - Elan Corporation plc
- Table of Contents: View Table of Contents
- Report Type: Company Profile
- Country: Global
- Number of Pages: 56
Introduction
Elan is a neuroscience-based biotechnology company that is focused on discovering, developing, manufacturing and marketing therapies in neurodegenerative diseases, autoimmune diseases, and severe pain. The company currently markets anti-infectives Maxipime and Azactam, as well as Tysabri, its landmark product co-developed with Biogen Idec.
During fiscal 2006, Elan generated approximately 51% of total revenues from EDT division and 49% from biopharmaceuticals division. The company earns revenues from product sales, royalties and licenses. Elan now has a balanced contribution from product sales and royalties, licenses, collaboration and other.
Tysabri is expected to be the main growth driver of revenues for Elan to 2010, generating sales growth of +$1,832 million during the period 2006-2010. Currently, Tysabri is indicated for the treatment for relapsing forms of multiple sclerosis (MS). The drug is currently in Phase III clinical trial for Crohn’s Disease.
Scope
Access all the important information and analysis on a company in a single report Understand company’s strengths, weaknesses, opportunities and threats along with business strategy and value chain Gain access to company’s adjusted five year financial data along with key ratios and market capitalization
Highlights
Reasons to Purchase
Scope
Highlights
Reasons to Purchase
Purchase Information
There are various ways to purchase products from our site. Select the report title(s) you are interested in, and add it to your basket. At the Checkout page, you will be requested to submit your details. You will then have the option to pay via various methods: Debit Card ; Credit Card ; Purchase via Invoice (inc. Purchase Order no. if required) and Paypal. Companiesandmarkets.com accepts Visa, MasterCard, Diners, American Express, JCB and all the major credit cards. Companiesandmarkets.com uses RBSWorldpay.
Once you have purchased your report(s), you will receive a confirmation email. You will then either be able to download your report(s) immediately from your Customer Area in PDF format, or the report(s) will be emailed to you directly, depending on the agreement we have with the publisher. Orders that are deliverable via email which are taken outside of working hours will be delivered next business day.
Please note, if you purchase by invoice, you will receive your report(s) once payment has been received. If you have any questions about how to order, please Contact Us.
